Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals - 01/10/22
Doi : 10.1016/j.clinre.2022.102011
Taiki Okumura a, Satoru Joshita a, b, ⁎ 
, Ayumi Sugiura a, Masao Ota a, b, Takeji Umemura a, b, c, d
, Ayumi Sugiura a, Masao Ota a, b, Takeji Umemura a, b, c, d a Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan
b Department of Health Promotion Medicine, Shinshu University School of Medicine, Matsumoto, Japan
c Department of Advanced Therapeutic Endoscopy, Shinshu University School of Medicine, Matsumoto, Japan
d Consultation Center for Liver Diseases, Shinshu University Hospital, Matsumoto, Japan
⁎Corresponding authorat: 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan3-1-1 Asahi, MatsumotoNagano390-8621Japan
Highlights |
• | Serum Lp(a) level displayed a significant increase in HCV patients achieving an SVR with direct-acting antivirals. |
• | Lp(a) values showed no significant association with either the SNP at rs3798220 or (TTTTA)n repeat polymorphisms. |
• | The impact of higher Lp(a) values and clinical outcomes, such as the risk of cardiovascular events or carcinogenesis, requires further investigation. |
Graphical abstract |
:
Graphical abstract
Graphical abstractImage, graphical abstractLe texte complet de cet article est disponible en PDF.
Keywords : Lipoprotein(a), Direct-acting antivirals, Chronic hepatitis C
© 2022
Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 8
Article 102011- octobre 2022 Retour au numéro
Article précédent
- Pathological complete response of liver metastases of cholangiocarcinoma using hepatic intra-arterial gemcitabine-oxaliplatin
- Diana Maria Bran, David Fuks, Alexandre Lansier, Claire Gallois, Mehdi Karoui, Julien Taieb, Widad Lahlou
- Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature
- Gonzalo González-Morcillo, Beatriz Calderón-Hernanz, Joaquín Serrano-López de las Hazas, Ana Isabel de Hita-Santabaya, Joan Riera-Oliver
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?